Log In
Print
BCIQ
Print
Print this Print this
 

MLR-1023

  Manage Alerts
Collapse Summary General Information
Company Melior Discovery Inc.
DescriptionLyn kinase activator
Molecular Target Lyn kinase (LYN)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner

Bukwang Pharmaceutical Co. Ltd.; Pfizer Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today